What is Brook?
Brook.ai operates at the intersection of health technology and clinical service, offering a platform that blends intelligent data analysis with human-led care. By moving away from the traditional model of reactive, intermittent medical check-ups, the company provides an always-on care environment. This approach leverages AI to monitor patient health metrics continuously, while simultaneously deploying skilled health specialists to provide compassionate, actionable support. The platform is designed to augment existing healthcare infrastructure, effectively bridging the gap between clinical data collection and patient outcomes in a remote setting.
How much funding has Brook raised?
Brook has raised a total of $28.1M across 2 funding rounds:
Debt
$150K
Series B
$28M
Debt (2020): $150K with participation from PPP
Series B (2025): $28M led by Morningside and UMass Memorial Health
Key Investors in Brook
Morningside
A professional services firm with deep expertise in life sciences and global communication, providing strategic support for companies navigating complex regulatory and clinical environments.
UMass Memorial Health
The largest healthcare system in Central Massachusetts, serving as a premier clinical partner for research, technology integration, and advanced medical trials.
PPP
Public-Private Partnership
What's next for Brook?
With the successful closure of this Series B round, Brook.ai is well-positioned to accelerate its market penetration and enhance its proprietary AI diagnostic capabilities. The strategic focus will likely shift toward scaling its clinical operations and expanding its footprint within the enterprise healthcare sector. By leveraging the expertise of its institutional backers, the company aims to solidify its role as a leader in the proactive care paradigm, potentially integrating more deeply with large-scale health systems to improve chronic disease management and patient engagement metrics on a national level.
See full Brook company page
